X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15308) 15308
Newsletter (134) 134
Book / eBook (78) 78
Book Chapter (65) 65
Magazine Article (16) 16
Newspaper Article (5) 5
Web Resource (5) 5
Conference Proceeding (4) 4
Dissertation (4) 4
Book Review (3) 3
Publication (3) 3
Reference (3) 3
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13222) 13222
oncology (6776) 6776
female (6328) 6328
male (6324) 6324
cancer (5903) 5903
middle aged (5010) 5010
aged (4215) 4215
tumors (3991) 3991
adult (3713) 3713
research article (3278) 3278
medicine (3272) 3272
animals (2961) 2961
science (2879) 2879
multidisciplinary sciences (2857) 2857
gastrointestinal tumors (2750) 2750
colorectal cancer (2614) 2614
research (2569) 2569
cancers and neoplasms (2435) 2435
mutation (2380) 2380
surgery (2339) 2339
prognosis (2312) 2312
pathology (2254) 2254
analysis (2229) 2229
gastrointestinal diseases (2089) 2089
gene expression (2051) 2051
genetic aspects (2004) 2004
metastasis (1991) 1991
gastroenterology and hepatology (1980) 1980
expression (1948) 1948
immunohistochemistry (1868) 1868
gastroenterology & hepatology (1843) 1843
aged, 80 and over (1829) 1829
risk factors (1809) 1809
gastrointestinal neoplasms - genetics (1808) 1808
health aspects (1797) 1797
care and treatment (1770) 1770
mice (1764) 1764
proteins (1714) 1714
diagnosis (1702) 1702
patients (1684) 1684
biology (1636) 1636
cell line, tumor (1629) 1629
gastrointestinal stromal tumors (1474) 1474
gastrointestinal neoplasms - pathology (1403) 1403
chemotherapy (1387) 1387
development and progression (1335) 1335
studies (1324) 1324
medicine and health sciences (1320) 1320
medical prognosis (1319) 1319
apoptosis (1313) 1313
genes (1293) 1293
genetics (1292) 1292
medicine & public health (1262) 1262
cell biology (1258) 1258
digestive system diseases (1246) 1246
survival (1246) 1246
medical research (1238) 1238
gene expression regulation, neoplastic (1203) 1203
gastroenterology (1161) 1161
kinases (1126) 1126
signal transduction (1118) 1118
colorectal-cancer (1107) 1107
colon (1105) 1105
biology and life sciences (1100) 1100
stomach cancer (1100) 1100
liver cancer (1081) 1081
stomach neoplasms - pathology (1043) 1043
cancer therapies (1039) 1039
proto-oncogene proteins c-kit - genetics (1033) 1033
carcinoma (1030) 1030
gastrointestinal stromal tumors - pathology (1026) 1026
gastric cancer (1023) 1023
treatment outcome (1015) 1015
risk (1013) 1013
gastrointestinal cancers (1011) 1011
imatinib mesylate (984) 984
colorectal neoplasms - genetics (983) 983
retrospective studies (983) 983
gastrointestinal stromal tumors - genetics (972) 972
biomarkers (960) 960
epidemiology (950) 950
hospitals (949) 949
neoplasms (947) 947
colorectal neoplasms - pathology (934) 934
colon cancer (929) 929
metastases (927) 927
adenocarcinoma (923) 923
antineoplastic agents - therapeutic use (923) 923
gastrointestinal cancer (910) 910
liver (901) 901
colorectal carcinoma (878) 878
hepatocellular carcinoma (874) 874
biochemistry (860) 860
dna (853) 853
mutations (848) 848
cell proliferation (839) 839
deoxyribonucleic acid--dna (839) 839
polymerase chain reaction (828) 828
cancer treatment (821) 821
neoplasm staging (820) 820
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
Online Resources - Online (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Scarborough Hospital - General (3) 3
St. Michael's Hospital - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Scarborough Hospital - Online (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Reference (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St Josephs Health Centre - Stacks (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15257) 15257
German (112) 112
Japanese (108) 108
French (85) 85
Chinese (72) 72
Spanish (35) 35
Russian (30) 30
Italian (16) 16
Polish (14) 14
Hungarian (13) 13
Danish (9) 9
Czech (7) 7
Portuguese (6) 6
Dutch (4) 4
Swedish (4) 4
Finnish (3) 3
Korean (3) 3
Norwegian (3) 3
Arabic (1) 1
Croatian (1) 1
Slovak (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 127 - 135
Purpose To examine the risk of subsequent primary malignancies (SPMs) in women diagnosed with endometrial cancer. Methods and Materials The National Cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Journal Article
Seminars in Oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
The fibroblast growth factor receptor (FGFR) pathway plays a major role in several biological processes, from organogenesis to metabolism homeostasis and... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 11, pp. 2563 - 2570
Summary BRAF mutation is seen in a variety of human neoplasms including cutaneous malignant melanoma, papillary thyroid carcinoma, colorectal carcinoma, non... 
Pathology | Immunohistochemistry | Anti–B-Raf | BRAF V600E | VE1 | Glioma | Melanoma | Thyroid carcinoma | Anti-B-Raf | PROTEIN | IMPROVED SURVIVAL | PATHOLOGY | CANCER | TUMORS | THERAPY | MEK INHIBITION | GENE | MUTANT BRAF | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Mutation, Missense | Breast Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Ovarian Neoplasms - genetics | Gastrointestinal Neoplasms - pathology | Neoplasms - genetics | DNA Mutational Analysis | Melanoma - genetics | Glioma - pathology | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Carcinoma - pathology | Antibodies, Monoclonal - immunology | Proto-Oncogene Proteins B-raf - metabolism | Gastrointestinal Neoplasms - metabolism | Lung Neoplasms - genetics | Melanoma - metabolism | Mutant Proteins - genetics | Mutant Proteins - metabolism | Melanoma - pathology | Thyroid Neoplasms - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Proto-Oncogene Proteins B-raf - genetics | Carcinoma - genetics | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasms - pathology | Amino Acid Substitution | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Carcinoma | Gene mutations | Gliomas | Thyroid diseases | Monoclonal antibodies | Genetic aspects | Comparative analysis | Lung cancer, Non-small cell | Cancer | Breast cancer | Mutation | Tumors | Skin cancer
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 137, Issue 6, pp. 1976 - 1985.e10
Background & Aims MUTYH -associated polyposis (MAP) is characterized by a lifetime risk of colorectal cancer of up to 100%. However, no systematic evaluation... 
Gastroenterology and Hepatology | BASE-EXCISION-REPAIR | URINARY-TRACT CANCER | APC GENE MUTATION | MUIR-TORRE-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | DUODENAL ADENOMATOSIS | FAMILIAL ADENOMATOUS POLYPOSIS | MYH-ASSOCIATED POLYPOSIS | LYNCH SYNDROME | GASTROENTEROLOGY & HEPATOLOGY | MSH2 MUTATION CARRIERS | Gastrointestinal Neoplasms - genetics | Humans | Middle Aged | Adenomatous Polyposis Coli - epidemiology | Ovarian Neoplasms - pathology | Male | Adenomatous Polyposis Coli - pathology | Incidence | Ovarian Neoplasms - genetics | Young Adult | Gastrointestinal Neoplasms - pathology | Gastrointestinal Neoplasms - epidemiology | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Adult | Female | Retrospective Studies | Endoscopy | Adenomatous Polyposis Coli - genetics | Child | Urinary Bladder Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Skin Neoplasms - pathology | Genetic Predisposition to Disease | Sebaceous Gland Neoplasms - epidemiology | Risk Assessment | Risk Factors | Sebaceous Gland Neoplasms - genetics | DNA Glycosylases - genetics | Kaplan-Meier Estimate | Europe - epidemiology | Skin Neoplasms - epidemiology | Ovarian Neoplasms - epidemiology | Phenotype | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Sebaceous Gland Neoplasms - pathology | Skin Neoplasms - genetics | Adolescent | Age of Onset | Aged | Medical colleges | Animal pigments | Genetic disorders | Oncology, Experimental | Colorectal cancer | Research | Cancer | Tumors | Medical informatics
Journal Article
Oncogene, ISSN 0950-9232, 04/2008, Volume 27, Issue 18, pp. 2635 - 2647
TMPRSS4 is a novel type II transmembrane serine protease found at the cell surface that is highly expressed in pancreatic, colon and gastric cancer tissues.... 
Serine protease | Metastasis | E-cadherin | EMT | Invasion | TMPRSS4 | PROSTATE | MATRIPTASE | SURFACE PROTEOLYTIC-ENZYMES | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | serine protease | CELL BIOLOGY | BREAST-CANCER CELLS | MATRIX METALLOPROTEINASES | invasion | PLASMINOGEN-ACTIVATOR | ONCOLOGY | metastasis | GENETICS & HEREDITY | TRANSMEMBRANE SERINE PROTEASES | EXPRESSION | RNA, Small Interfering - genetics | Cadherins - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | Cell Movement - genetics | Neoplasm Metastasis | Serine Endopeptidases - genetics | Liver Neoplasms - pathology | Cadherins - genetics | Liver Neoplasms - enzymology | Liver Neoplasms - secondary | Neoplasm Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Lung Neoplasms - enzymology | Liver Neoplasms - genetics | Serine Endopeptidases - biosynthesis | Membrane Proteins - genetics | Epithelial Cells - pathology | Lung Neoplasms - therapy | Gastrointestinal Neoplasms - enzymology | Gastrointestinal Neoplasms - therapy | Cell Adhesion | Cell Movement - drug effects | Membrane Proteins - biosynthesis | Membrane Proteins - antagonists & inhibitors | Gene Expression Regulation, Enzymologic - genetics | Mice, Nude | Cell Communication - drug effects | Epithelial Cells - enzymology | Cell Line, Tumor | Biomarkers, Tumor - genetics | Cadherins - antagonists & inhibitors | Mice | RNA-Binding Proteins - metabolism | Gene Expression Regulation, Enzymologic - drug effects | Neoplasm Transplantation | RNA-Binding Proteins - genetics | Gastrointestinal Neoplasms - genetics | Lung Neoplasms - pathology | Liver Neoplasms - therapy | Gastrointestinal Neoplasms - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lung Neoplasms - genetics | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | Cell Communication - genetics | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Animals | Biomarkers, Tumor - biosynthesis | Care and treatment | Control | Proteases | Cancer cells | Physiological aspects | Genetic aspects | Research | Risk factors | Oncology | Genetics | Cellular biology | Pancreatic cancer | Colorectal cancer
Journal Article
British journal of cancer, ISSN 1532-1827, 2017, Volume 116, Issue 6, pp. 802 - 810
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 6, p. e0179501
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully... 
CD2 | THERAPY | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | GENES | IMMUNOMODULATORY ACTION | MECHANISMS | MOLECULES | SGI-110 | Colonic Neoplasms - genetics | DNA Methylation - immunology | DNA, Neoplasm - metabolism | Humans | Antigens, Neoplasm - biosynthesis | Ovarian Neoplasms - pathology | Male | Colonic Neoplasms - metabolism | Testicular Neoplasms - pathology | Ovarian Neoplasms - genetics | Colonic Neoplasms - immunology | Female | Ovarian Neoplasms - metabolism | Caco-2 Cells | Antigens, Neoplasm - genetics | Testicular Neoplasms - genetics | Antigens, Neoplasm - immunology | Testicular Neoplasms - metabolism | Antigen Presentation - genetics | DNA Methylation - genetics | Testicular Neoplasms - immunology | Animals | Colonic Neoplasms - pathology | DNA, Neoplasm - immunology | Mice | DNA, Neoplasm - genetics | Ovarian Neoplasms - immunology | Colon cancer | Tumor antigens | Physiological aspects | Development and progression | Genetic aspects | Research | Methylation | Ovarian cancer | Therapy | Biotechnology | Animal models | Ovarian carcinoma | Medical innovations | CD58 antigen | Antigen processing | Genomes | Tissues | Cancer therapies | Immunotherapy | Surgery | Cell cycle | DNA methylation | Inhibition | Colon | Drug dosages | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Antigens | Tumor cells | Melanoma | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Patients | Medicine | Inhibitors | Epigenetics | Solid tumors | Tumors | Cancer | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 1, pp. 173 - 177
Multiple primary malignancy is defined as two or more malignancies detected in an individual person. In particular, synchronous quintuple primary malignancy is... 
Colon neoplasm | Small bowel neoplasm | Synchronous quintuple primary cancer | Stomach neoplasm | PRIMARY CANCERS | NEOPLASMS | KIDNEY | GASTROENTEROLOGY & HEPATOLOGY | Rectal Neoplasms - diagnosis | Ileostomy | Colonic Neoplasms - genetics | Jejunal Neoplasms - genetics | Microsatellite Instability | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Colonic Neoplasms - diagnosis | Male | Stomach Neoplasms - pathology | Tomography, X-Ray Computed | Colectomy | Chemoradiotherapy, Adjuvant | Fluorouracil - therapeutic use | Neoplasms, Multiple Primary - therapy | Gastrectomy - methods | Rectal Neoplasms - genetics | Leucovorin - therapeutic use | Rectal Neoplasms - pathology | Adenocarcinoma, Mucinous - therapy | Neoplasms, Multiple Primary - diagnosis | Colonic Neoplasms - therapy | Stomach Neoplasms - genetics | Neoplasms, Multiple Primary - genetics | Stomach Neoplasms - diagnosis | Jejunal Neoplasms - therapy | Biomarkers, Tumor - analysis | Stomach Neoplasms - therapy | Endoscopy, Gastrointestinal | Neoplasms, Multiple Primary - pathology | Rectal Neoplasms - therapy | Jejunal Neoplasms - diagnosis | Positron Emission Tomography Computed Tomography | Adenocarcinoma, Mucinous - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gastrointestinal Hemorrhage - etiology | Cancer Pain - etiology | Colonic Neoplasms - pathology | Adenocarcinoma, Mucinous - genetics | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Jejunal Neoplasms - pathology | Case Report
Journal Article
Modern pathology, ISSN 1530-0285, 2011, Volume 24, Issue 12, pp. 1560 - 1570
Journal Article
Nature medicine, ISSN 1546-170X, 2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GASTROINTESTINAL-TRACT | AUTOCHTHONOUS PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | TRANSGENIC ADENOCARCINOMA | MOUSE MODEL | N-MYC | MUTATIONAL LANDSCAPE | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 3, p. e91811
...) and desmin to identify CAFs, and PTEN to examine genetic changes of CAFs. To evaluate the regional heterogeneity of these properties, we examined tissue from four sites... 
HETEROGENEITY | SURVIVAL | MULTIDISCIPLINARY SCIENCES | BREAST CARCINOMAS | PTEN | MICROVESSEL DENSITY | STROMA | MUTATIONS | LYMPHATIC VESSEL DENSITY | TUMOR-GROWTH | EXPRESSION | Prognosis | Lung Neoplasms - mortality | Colorectal Neoplasms - genetics | Humans | Middle Aged | Neovascularization, Pathologic | Microvessels - pathology | Male | Ovarian Neoplasms - mortality | Liver Neoplasms - mortality | Actins - genetics | Ovarian Neoplasms - genetics | Lymphatic Vessels - blood supply | Ovarian Neoplasms - secondary | Lung Neoplasms - secondary | Aged, 80 and over | Peritoneal Neoplasms - blood supply | Adult | Female | Ovarian Neoplasms - blood supply | Liver Neoplasms - secondary | Lung Neoplasms - blood supply | Peritoneal Neoplasms - secondary | Colorectal Neoplasms - mortality | Lung Neoplasms - genetics | PTEN Phosphohydrolase - genetics | Colorectal Neoplasms - blood supply | Liver Neoplasms - genetics | Lymphatic Metastasis | Fibroblasts - pathology | Peritoneal Neoplasms - mortality | Liver Neoplasms - blood supply | Peritoneal Neoplasms - genetics | Lymphatic Vessels - pathology | Survival Analysis | Desmin - genetics | Aged | Biomarkers, Tumor - genetics | Colorectal Neoplasms - pathology | Immunohistochemistry | Cancer patients | Care and treatment | Metastasis | Muscle proteins | Colorectal cancer | Liver | Colorectal carcinoma | Regional analysis | Muscles | Smooth muscle | Patients | Desmin | Lymph nodes | Metastases | Studies | Pathology | Heterogeneity | Lungs | Actin | Rodents | Fibroblasts | Microenvironments | Microvasculature | Mutation | PTEN protein | Cancer | Peritoneum
Journal Article